\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ physical\\ exam\\ or\\ laboratory\\ findings\\ available\\.\ \(0\)\
\-\ the\\ patient\\ was\\ treated\\ with\\ a\\ whipple\\ procedure\\.\ \(0\)\
\-\ us\\ findings\\:\\ \\ the\\ common\\ bile\\ duct\\ measures\\ 14mm\\ with\\ this\\ pancreatic\\ parenchymal\\ tissue\\ and\\ pancreatic\\ duct\\ dilatation\\,\\ measuring\\ 5mm\\ in\\ diameter\\.\\ \\ these\\ findings\\ were\\ concerning\\ for\\ mucinous\\ duct\\ ecstatic\\ pancreatic\\ carcinoma\\ vs\\.\\ pancreatic\\ head\\ neoplasm\\.\ \(0\)\
\-\ ct\\ findings\\:\\ \\ a\\ 23\\ x\\ 21\\ mm\\ heterogeneous\\ mass\\ is\\ visualized\\ within\\ the\\ head\\ of\\ the\\ pancreas\\ with\\ moderate\\ dilatation\\ of\\ the\\ pancreatic\\ duct\\ as\\ well\\ as\\ marked\\ extra\\-\\ and\\ moderate\\ intra\\-hepatic\\ ductal\\ dilatation\\.\\ \\ the\\ sma\\ and\\ smv\\ fat\\ planes\\ appear\\ preserved\\.\ \(0\)\
\-\ pancreatic\\ adenocarinoma\\,\\ well\\-to\\-moderately\\ differentiated\\.\ \(0\)\
\-\ pancreatic\\ adenocarcinoma\ \(3\)\
\-\ mucinous\\ duct\\ ectatic\\ pancreatic\\ carcinoma\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ cholecystitis\ \(124\)\
\-\ 60yo\\ female\\ with\\ history\\ of\\ abdominal\\ lymphoma\\ presents\\ to\\ the\\ er\\ with\\ abdominal\\ pain\\.\ \(0\)\
\-\ pancreatic\\ adenocarcinoma\\ accounts\\ for\\ 3\\%\\ of\\ all\\ cancers\\ and\\ is\\ commonly\\ unresectable\\ at\\ time\\ of\\ presentation\\ giving\\ an\\ average\\ survival\\ time\\ of\\ 5\\-8\\ months\\.\\ \\ when\\ assessing\\ the\\ lesion\\ radiographically\\,\\ care\\ must\\ be\\ taken\\ to\\ determine\\ respectability\\,\\ as\\ surgery\\ \\(i\\.e\\.\\ whipple\\ procedure\\)\\ is\\ the\\ only\\ hope\\ of\\ cure\\.\\ \\ \ \(0\)\
\-\ sonographically\\,\\ adenocarcinoma\\ appears\\ as\\ a\\ hypoechoic\\ mass\\ or\\ just\\ a\\ subtle\\ alteration\\ of\\ echotexture\\ of\\ the\\ pancreas\\.\\ \\ biliary\\ and\\ pancreatic\\ ductal\\ dilatation\\ can\\ easily\\ be\\ identified\\ and\\ may\\ be\\ the\\ only\\ abnormality\\ identified\\.\\ \\ characteristically\\,\\ the\\ dilated\\ ducts\\ will\\ terminate\\ into\\ a\\ hypoechoic\\ mass\\.\\ \\ if\\ the\\ portal\\ vein\\,\\ superior\\ mesenteric\\ artery\\,\\ superior\\ mesenteric\\ vein\\,\\ hepatic\\ artery\\ or\\ celiac\\ trunk\\ are\\ seen\\ to\\ be\\ encased\\ in\\ tumor\\ or\\ involved\\ with\\ direct\\ tumor\\ invasion\\,\\ the\\ lesion\\ is\\ determined\\ to\\ be\\ non\\-resectable\\.\\ \\ also\\,\\ if\\ liver\\ or\\ peritoneal\\ metastases\\ are\\ identified\\,\\ the\\ lesion\\ is\\ not\\ resectable\\.\\ \ \(0\)\
\-\ on\\ ct\\,\\ pancreatic\\ adenocarcinoma\\ appears\\ as\\ a\\ hypodense\\ mass\\ distorting\\ the\\ contour\\ of\\ the\\ pancreas\\ with\\ common\\ bile\\ duct\\ and\\ pancreatic\\ duct\\ dilatation\\ and\\ possible\\ atrophy\\ of\\ the\\ remaining\\ pancreatic\\ tissue\\.\\ \\ criteria\\ for\\ non\\-resectability\\ on\\ ct\\ include\\ extension\\ of\\ the\\ tumor\\ beyond\\ the\\ margins\\ of\\ the\\ pancreas\\,\\ tumor\\ involvement\\ of\\ adjacent\\ organs\\,\\ enlarged\\ regional\\ lymph\\ nodes\\ \\(\\>15mm\\)\\,\\ encasement\\ or\\ involvement\\ of\\ peripancreatic\\ vessels\\,\\ metastases\\ in\\ the\\ liver\\,\\ or\\ peritoneal\\ carcinomatosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pancreatic\\:\\ 0\\.5486876543118587\ \(0\)\
\-\ duct\\:\\ 0\\.2805422867339807\ \(0\)\
\-\ the\\:\\ 0\\.20437877777629998\ \(0\)\
\-\ dilatation\\:\\ 0\\.19003086187816387\ \(0\)\
\-\ pancreas\\:\\ 0\\.1750313360196602\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.1522128575331058\ \(0\)\
\-\ of\\:\\ 0\\.1366669826806139\ \(0\)\
\-\ whipple\\:\\ 0\\.12435988172793627\ \(0\)\
\-\ resectable\\:\\ 0\\.12108422731685707\ \(0\)\
\-\ or\\:\\ 0\\.11337611838198411\ \(0\)\
\-\ mucinous\\:\\ 0\\.09960773577639005\ \(0\)\
\-\ identified\\:\\ 0\\.09902406823062575\ \(0\)\
\-\ tumor\\:\\ 0\\.09740947453215164\ \(0\)\
\-\ be\\:\\ 0\\.09443295037539487\ \(0\)\
\-\ as\\:\\ 0\\.0935193648698494\ \(0\)\
\-\ findings\\:\\ 0\\.09191233286703733\ \(0\)\
\-\ bile\\:\\ 0\\.09041605229684914\ \(0\)\
\-\ peritoneal\\:\\ 0\\.0875156680098301\ \(0\)\
\-\ ductal\\:\\ 0\\.0819421083863457\ \(0\)\
\-\ mesenteric\\:\\ 0\\.0803985783877693\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.07956129068299303\ \(0\)\
\-\ and\\:\\ 0\\.07696459888558271\ \(0\)\
\-\ metastases\\:\\ 0\\.07527857935719018\ \(0\)\
\-\ respectability\\:\\ 0\\.07445586821850303\ \(0\)\
\-\ terminate\\:\\ 0\\.07445586821850303\ \(0\)\
\-\ procedure\\:\\ 0\\.07423629784525894\ \(0\)\
\-\ hepatic\\:\\ 0\\.07415237204874997\ \(0\)\
\-\ 60yo\\:\\ 0\\.07114655699382617\ \(0\)\
\-\ mass\\:\\ 0\\.07113516572973033\ \(0\)\
\-\ moderate\\:\\ 0\\.06990188883107237\ \(0\)\
\-\ ecstatic\\:\\ 0\\.06879856331332183\ \(0\)\
\-\ distorting\\:\\ 0\\.06879856331332183\ \(0\)\
\-\ appears\\:\\ 0\\.06818848640292681\ \(0\)\
\-\ involvement\\:\\ 0\\.06739482508883031\ \(0\)\
\-\ 14mm\\:\\ 0\\.06697731792299993\ \(0\)\
\-\ adenocarinoma\\:\\ 0\\.06697731792299993\ \(0\)\
\-\ lesion\\:\\ 0\\.06696236452554845\ \(0\)\
\-\ vein\\:\\ 0\\.06674396685579856\ \(0\)\
\-\ encased\\:\\ 0\\.06548925208864499\ \(0\)\
\-\ liver\\:\\ 0\\.06423528102462715\ \(0\)\
\-\ unresectable\\:\\ 0\\.06423111035254318\ \(0\)\
\-\ with\\:\\ 0\\.06381603254609315\ \(0\)\
\-\ is\\:\\ 0\\.06375068684285504\ \(0\)\
\-\ hope\\:\\ 0\\.062179940863968136\ \(0\)\
\-\ 15mm\\:\\ 0\\.062179940863968136\ \(0\)\
\-\ ectatic\\:\\ 0\\.060542113658428535\ \(0\)\
\-\ peripancreatic\\:\\ 0\\.060542113658428535\ \(0\)\
\-\ superior\\:\\ 0\\.06053816599402576\ \(0\)\
\-\ smv\\:\\ 0\\.05917865735491732\ \(0\)\
\-\ cure\\:\\ 0\\.05917865735491732\ \(0\)\
\-\ to\\:\\ 0\\.05819664450167757\ \(0\)\
\-\ only\\:\\ 0\\.05817319650683681\ \(0\)\
\-\ encasement\\:\\ 0\\.05801070179314189\ \(0\)\
\-\ artery\\:\\ 0\\.05783084106746138\ \(0\)\
\-\ sonographically\\:\\ 0\\.056989149542132835\ \(0\)\
\-\ carcinoma\\:\\ 0\\.05569740135170261\ \(0\)\
\-\ characteristically\\:\\ 0\\.05566270811263755\ \(0\)\
\-\ head\\:\\ 0\\.05553604717336599\ \(0\)\
\-\ lymphoma\\:\\ 0\\.055455964274575775\ \(0\)\
\-\ assessing\\:\\ 0\\.05526449422268514\ \(0\)\
\-\ time\\:\\ 0\\.05519182369778233\ \(0\)\
\-\ alteration\\:\\ 0\\.05488480875324735\ \(0\)\
\-\ if\\:\\ 0\\.054102339760203275\ \(0\)\
\-\ giving\\:\\ 0\\.05352135244973613\ \(0\)\
\-\ ct\\:\\ 0\\.05317483930623708\ \(0\)\
\-\ common\\:\\ 0\\.052807076243225906\ \(0\)\
\-\ sma\\:\\ 0\\.052630093410672006\ \(0\)\
\-\ accounts\\:\\ 0\\.051826648597778274\ \(0\)\
\-\ echotexture\\:\\ 0\\.051826648597778274\ \(0\)\
\-\ trunk\\:\\ 0\\.051826648597778274\ \(0\)\
\-\ regional\\:\\ 0\\.051826648597778274\ \(0\)\
\-\ abdominal\\:\\ 0\\.05092726195481993\ \(0\)\
\-\ celiac\\:\\ 0\\.05064170704499891\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.0504240470598445\ \(0\)\
\-\ cancers\\:\\ 0\\.05000540320745636\ \(0\)\
\-\ 5mm\\:\\ 0\\.04960718931750395\ \(0\)\
\-\ preserved\\:\\ 0\\.04886469897561068\ \(0\)\
\-\ tissue\\:\\ 0\\.04884622054802079\ \(0\)\
\-\ average\\:\\ 0\\.04851733737310142\ \(0\)\
\-\ beyond\\:\\ 0\\.04851733737310142\ \(0\)\
\-\ planes\\:\\ 0\\.04802253341227479\ \(0\)\
\-\ ducts\\:\\ 0\\.04802253341227479\ \(0\)\
\-\ organs\\:\\ 0\\.04802253341227479\ \(0\)\
\-\ easily\\:\\ 0\\.046561183692548476\ \(0\)\
\-\ radiographically\\:\\ 0\\.046428469130520816\ \(0\)\
\-\ criteria\\:\\ 0\\.046169343692597085\ \(0\)\
\-\ survival\\:\\ 0\\.045437950246677704\ \(0\)\
\-\ hypodense\\:\\ 0\\.04520802614842457\ \(0\)\
\-\ well\\:\\ 0\\.045086917702530614\ \(0\)\
\-\ cholecystitis\\:\\ 0\\.0448748465924576\ \(0\)\
\-\ concerning\\:\\ 0\\.0446600508872875\ \(0\)\
\-\ portal\\:\\ 0\\.044554736319878094\ \(0\)\
\-\ differentiated\\:\\ 0\\.04445076337583515\ \(0\)\
\-\ determined\\:\\ 0\\.04434809830227517\ \(0\)\
\-\ remaining\\:\\ 0\\.044246708604252054\ \(0\)\
\-\ atrophy\\:\\ 0\\.044047631278001764\ \(0\)\
\-\ determine\\:\\ 0\\.04329659458377628\ \(0\)\
\-\ biliary\\:\\ 0\\.04329659458377628\ \(0\)\
\-\ for\\:\\ 0\\.0423338277642811\ \(0\)\
\-\ contour\\:\\ 0\\.04189871492374772\ \(0\)\
\-\ parenchymal\\:\\ 0\\.04182349074395328\ \(0\)\
\-\ invasion\\:\\ 0\\.041529341225399224\ \(0\)\
\-\ direct\\:\\ 0\\.04103878707759832\ \(0\)\
\-\ subtle\\:\\ 0\\.04013815208605969\ \(0\)\
\-\ must\\:\\ 0\\.039898082845752636\ \(0\)\
\-\ margins\\:\\ 0\\.03972255423696553\ \(0\)\
\-\ nodes\\:\\ 0\\.03955072124324338\ \(0\)\
\-\ 23\\:\\ 0\\.038390326372820575\ \(0\)\
\-\ measures\\:\\ 0\\.0379593999511746\ \(0\)\
\-\ diameter\\:\\ 0\\.03741809007687715\ \(0\)\
\-\ involved\\:\\ 0\\.037331261962969056\ \(0\)\
\-\ just\\:\\ 0\\.037245347846176224\ \(0\)\
\-\ 21\\:\\ 0\\.03720272756273904\ \(0\)\
\-\ taken\\:\\ 0\\.03720272756273904\ \(0\)\
\-\ us\\:\\ 0\\.03703443777103976\ \(0\)\
\-\ appear\\:\\ 0\\.036668012687510736\ \(0\)\
\-\ visualized\\:\\ 0\\.036355562449028454\ \(0\)\
\-\ lymph\\:\\ 0\\.03620371126456096\ \(0\)\
\-\ vessels\\:\\ 0\\.03612883215466327\ \(0\)\
\-\ measuring\\:\\ 0\\.03601778600995968\ \(0\)\
\-\ vs\\:\\ 0\\.03551865793473707\ \(0\)\
\-\ are\\:\\ 0\\.03533304533206518\ \(0\)\
\-\ marked\\:\\ 0\\.03521319238071785\ \(0\)\
\-\ er\\:\\ 0\\.03482291409249075\ \(0\)\
\-\ in\\:\\ 0\\.034746120442781823\ \(0\)\
\-\ commonly\\:\\ 0\\.03445044950800728\ \(0\)\
\-\ abnormality\\:\\ 0\\.033865125960581444\ \(0\)\
\-\ laboratory\\:\\ 0\\.033808837697952614\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.033697412544415155\ \(0\)\
\-\ dilated\\:\\ 0\\.033345441076925116\ \(0\)\
\-\ mm\\:\\ 0\\.03331898476289595\ \(0\)\
\-\ care\\:\\ 0\\.033266328027143355\ \(0\)\
\-\ extension\\:\\ 0\\.03295732838347431\ \(0\)\
\-\ presentation\\:\\ 0\\.03204953080636717\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03178263730183528\ \(0\)\
\-\ enlarged\\:\\ 0\\.03173899139177331\ \(0\)\
\-\ available\\:\\ 0\\.031588042940995036\ \(0\)\
\-\ possible\\:\\ 0\\.03154542265755785\ \(0\)\
\-\ adjacent\\:\\ 0\\.03017869707071372\ \(0\)\
\-\ will\\:\\ 0\\.029965769367092422\ \(0\)\
\-\ treated\\:\\ 0\\.02899278382131656\ \(0\)\
\-\ fat\\:\\ 0\\.028961750454150614\ \(0\)\
\-\ when\\:\\ 0\\.028123533568977743\ \(0\)\
\-\ on\\:\\ 0\\.028122437873946086\ \(0\)\
\-\ all\\:\\ 0\\.027714678522718098\ \(0\)\
\-\ include\\:\\ 0\\.027701396557652688\ \(0\)\
\-\ months\\:\\ 0\\.02710033729223415\ \(0\)\
\-\ these\\:\\ 0\\.02629111532854485\ \(0\)\
\-\ physical\\:\\ 0\\.025244643638460657\ \(0\)\
\-\ surgery\\:\\ 0\\.02503137871882165\ \(0\)\
\-\ into\\:\\ 0\\.024749261955762863\ \(0\)\
\-\ can\\:\\ 0\\.024431996247377522\ \(0\)\
\-\ were\\:\\ 0\\.023999139477629283\ \(0\)\
\-\ exam\\:\\ 0\\.023437160110997092\ \(0\)\
\-\ may\\:\\ 0\\.023429293348237217\ \(0\)\
\-\ female\\:\\ 0\\.02246622866379655\ \(0\)\
\-\ presents\\:\\ 0\\.022396647971862284\ \(0\)\
\-\ seen\\:\\ 0\\.021918979441509886\ \(0\)\
\-\ also\\:\\ 0\\.02189939902652543\ \(0\)\
\-\ within\\:\\ 0\\.02144303238705296\ \(0\)\
\-\ not\\:\\ 0\\.018379865131334376\ \(0\)\
\-\ an\\:\\ 0\\.01780350109120551\ \(0\)\
\-\ history\\:\\ 0\\.0177877295583143\ \(0\)\
\-\ at\\:\\ 0\\.017585425675020985\ \(0\)\
\-\ pain\\:\\ 0\\.016660051793923537\ \(0\)\
\-\ was\\:\\ 0\\.01622581291560317\ \(0\)\
\-\ this\\:\\ 0\\.01599805776919153\ \(0\)\
\-\ patient\\:\\ 0\\.015142876515633896\ \(0\)\
\-\ no\\:\\ 0\\.015140028228837761\ \(0\)\
